U.S. Medical Equipment Stock News

Coterra Energy (CTRA) has moved to voluntarily deregister its common stock and several senior notes by filing Form 15 with the SEC, marking a material shift in its reporting and disclosure obligations for investors. See our latest analysis for Coterra Energy. The share price has reacted sharply around these filings, with a 1-day share price return down 8.62% and a 7-day share price return down 7.97%. This follows a year-to-date share price return of 22.41% and a 1-year total shareholder...

In recent days, MP Materials reported first-quarter 2026 results that exceeded earnings and revenue expectations while highlighting progress on magnet production, heavy rare earth separations, and recycling initiatives underpinned by long-term contracts with Apple and the U.S. Department of Defense. At the same time, insider share sales, cooling commodity prices, and signs of looser Chinese export restrictions on rare earths have injected fresh uncertainty into how investors assess the...

Earlier in May 2026, WEX Inc. announced a US$1.00 billion open-ended share repurchase program and confirmed that independent director David Foss became Chair of the Board, while Melissa Smith remained Chief Executive Officer, President, and director. The company also reported first-quarter 2026 adjusted earnings of US$4.15 per diluted share, raised its full-year guidance, and outlined US$50.00 million of planned cost-saving measures through automation and modernization. With stronger...

On May 21, 2026, Reliance, Inc. reported that shareholders at its May 20 annual meeting rejected a proposal requiring directors to leave the Board within nine months if they failed to secure a majority vote. Alongside this governance outcome, Reliance’s first-quarter 2026 results beat earnings and sales estimates, supported by higher prices and stronger demand across several end markets. We’ll now examine how Reliance’s stronger-than-expected first-quarter performance and confident...

Celcuity (CELC) has drawn investor attention after recent trading that left the stock around $138.23, supported by a clinical stage pipeline focused on targeted therapies for solid tumors. See our latest analysis for Celcuity. The share price has cooled slightly in the last day, with a 1 day share price return showing a 3.02% decline. Momentum over longer periods remains strong, including a 30 day share price return of 14.21% and a very large 1 year total shareholder return that is above...

Why Chart Industries Stock Is Back On Investors’ Radar Chart Industries (GTLS) is drawing attention after recent trading around US$207.96, with investors weighing its current valuation against an intrinsic value estimate that implies roughly a 13% discount. See our latest analysis for Chart Industries. While the share price has barely shifted in recent weeks, the stronger 1 year total shareholder return of 31.74% and 3 year total shareholder return of 87.05% suggest momentum has been building...

Event context and recent share performance Aflac (AFL) has drawn investor attention after its shares last closed at $117.86, with returns of 0.04% over the past day, 0.9% over the past week and 2.8% over the past month. See our latest analysis for Aflac. Beyond the recent move, Aflac’s 1 year total shareholder return of 17.4% and 3 year total shareholder return of 94.9% point to momentum that has built steadily over time, even as short term share price returns remain more modest. If you...

In recent days, Moody’s reported that its evolving “two-engine” model, combining a recurring-revenue analytics franchise with its cyclical ratings arm, helped deliver strong quarterly results, record issuance-driven revenues, and increased capital returns through higher share repurchase guidance. An interesting aspect of this update is how Moody’s growing base of subscription analytics revenue appears to provide a more stable counterweight to the inherently cyclical ratings business,...

ConnectOne Bancorp (CNOB) recently filed a US$44.805 million shelf registration for up to 1,500,000 common shares tied to its Employee Stock Ownership Plan, highlighting the role of the ESOP in its capital structure. See our latest analysis for ConnectOne Bancorp. The ESOP related shelf registration comes as ConnectOne Bancorp’s share price sits at US$29.76, with a 7 day share price return of 2.83% and a 90 day share price return of 10.92%, alongside a 1 year total shareholder return of...

Earlier this week, Stellantis announced that it had expanded its multi-year technology collaboration with Qualcomm to integrate Snapdragon Digital Chassis and Snapdragon Ride Pilot platforms across millions of its future vehicles worldwide, deepening Qualcomm’s role in cockpit, connectivity and driver-assistance systems. This enlarged Stellantis deal further scales Qualcomm’s automotive revenue base and highlights how its chip and software platforms are being embedded as core infrastructure...

Why a wave of lawsuits has put Medpace Holdings (MEDP) in the spotlight Recent securities class actions against Medpace Holdings (MEDP) allege false and misleading statements about book to bill guidance, backlog cancellations, and business prospects, with investors pointing to fourth quarter 2025 results as the turning point. See our latest analysis for Medpace Holdings. Medpace’s share price has recently been volatile, with a 7 day share price return of 4.22% and a 30 day share price return...

Key metrics and recent performance snapshot Valmont Industries (VMI) has attracted fresh attention after recent trading, with the stock closing at $513.43. Investors are weighing this price against the company’s earnings profile, business mix and recent return history. The company reports revenue of $4.16b and net income of $355.56m, split across two main segments: Infrastructure at $3.20b and Agriculture at $980.48m, with intersegment sales of $15.22m. On a return basis, the stock shows a...

Academy Sports and Outdoors (ASO) is drawing fresh attention after announcing three new store openings this quarter in Altoona, Pennsylvania, and two Tennessee locations, paired with community donations and grand opening events. See our latest analysis for Academy Sports and Outdoors. These new openings come as the stock edges higher in the short term, with a 1-day share price return of 2.92% and 7-day share price return of 3.90%, while the 30-day and 90-day share price returns are down 8.17%...

Capri Holdings (CPRI) heads into its upcoming fiscal fourth quarter earnings report with expectations for a sharp earnings improvement, even as revenue is projected to decline. This puts cost control and brand performance in sharp focus. See our latest analysis for Capri Holdings. At a share price of $18.48, Capri Holdings has seen short term buying interest, with a 7 day share price return of 7.07%. However, the 30 day share price return is down 10.42% and the year to date share price return...

Icahn Enterprises (IEP) is back in focus after its latest earnings call, where management highlighted net asset value gains tied to CVR Energy, a continued quarterly dividend, and a sizable net loss driven largely by hedging losses. See our latest analysis for Icahn Enterprises. At a share price of US$7.55, Icahn Enterprises has seen its 1-month share price return fall 7.25%, while its 1-year total shareholder return is up 12.01% and 5-year total shareholder return is down 64.67%. This...

TeraWulf recently reported its Q1 2026 results, highlighting revenue heavily supported by high-performance computing lease income, a liquidity position of about US$3.10 billion in cash and restricted cash, and the acquisition of a Kentucky campus with access to 480 MW of grid-connected power. Alongside this expansion, the company is advancing construction at Lake Mariner and through its Abernathy joint venture, while senior executives saw large blocks of performance-based stock units vest,...

Earlier this month, Wabtec Corporation’s board declared a regular quarterly dividend of US$0.31 per share, payable on June 3, 2026, to shareholders of record as of May 22, 2026. This dividend decision follows a stronger-than-expected first quarter for Westinghouse Air Brake Technologies, where earnings outpaced forecasts on the back of higher sales, margin expansion, and contributions from recent acquisitions such as Dellner Couplers. We’ll now examine how Wabtec’s earnings beat and raised...

In recent days, Generac Holdings drew attention after a major Wall Street firm upgraded its rating, highlighting growing demand for the company’s backup power solutions in large AI-focused data centers and pointing to strong commercial and industrial sales following robust quarterly results. This spotlight on potential hyperscaler data-center contracts underscores how Generac’s role in critical power infrastructure is becoming increasingly central to the AI build-out story. We’ll now...

What Lithia Motors stock’s recent returns suggest Lithia Motors (LAD) has drawn investor attention after a mixed stretch, with the stock up around 0.6% over the past month but down about 10% over the past year. See our latest analysis for Lithia Motors. While Lithia Motors' 7 day share price return of 5.6% has picked up, the year to date share price return is down 16.8% and the 1 year total shareholder return is down 10.5%, which hints at fading momentum despite a 3 year total shareholder...

Arrowhead Pharmaceuticals recently highlighted that it is entering a pivotal period, with new regulatory approvals for REDEMPLO, early commercial traction, and upcoming Phase 3 readouts for the SHASTA-3 and SHASTA-4 trials in severe hypertriglyceridemia. An interesting aspect is management’s emphasis on REDEMPLO’s multi-billion-dollar peak sales potential alongside a solid cash position to support its cardiometabolic pipeline as key data and commercialization milestones approach. We’ll now...

Globe Life (GL) is back in focus after two closely timed events: quarterly results that slightly missed earnings estimates despite 11.7% growth in net operating income, and an analyst downgrade that introduced a more cautious stance. See our latest analysis for Globe Life. The stock has been relatively steady around US$156.28 after the earnings miss and guidance raise, with a 30 day share price return of 2.44% and a 1 year total shareholder return of 31.99%. This points to momentum that has...

Earlier this month, Moderna announced that the FDA will convene a public advisory committee on June 18, 2026, to review its mRNA-based seasonal flu vaccine for adults aged 50 and older after an initial refusal-to-file setback. This review represents a pivotal regulatory test of Moderna’s efforts to build revenue beyond COVID-19 vaccines and prove the broader value of its mRNA platform. We’ll now examine how the upcoming FDA advisory panel decision on Moderna’s mRNA flu vaccine could reshape...

Earlier this month, JBT Marel Corporation’s board approved a quarterly cash dividend of US$0.10 per share and launched a US$200.00 million share repurchase program running through May 31, 2029. Together, the ongoing dividend and long-dated buyback authorization highlight the company’s focus on direct capital returns alongside its broader food technology growth ambitions. Now, we’ll examine how the newly announced US$200.00 million buyback aligns with and potentially reshapes JBT Marel’s...

Capricor Therapeutics (CAPR) has been in focus after a Roth Capital analyst lowered expectations, removing a US$80 million milestone and pushing the projected U.S. Deramiocel launch to 2027 following legal action involving NS Pharma. See our latest analysis for Capricor Therapeutics. The legal uncertainty around Deramiocel and the revised commercial timeline appear to be contributing to recent volatility, with the share price down about 18% over the last month but still showing very strong 1...